Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ZDHHC7 | Q9NXF8 | 1/20 | 0.63 |
| ▸ | GPR84 | Q9NQS5 | 7/20 | 0.61 |
| ▸ | FFAR1 | O14842 | 2/20 | 0.61 |
| ▸ | ABCB1 | P08183 | 1/20 | 0.53 |
| ▸ | CA1 | P00915 | 1/20 | 0.52 |
| ▸ | CA2 | P00918 | 1/20 | 0.52 |
| ▸ | USP2 | O75604 | 1/20 | 0.47 |
| ▸ | LMNA | P02545 | 1/20 | 0.47 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.46 |
| ▸ | NAAA | Q02083 | 1/20 | 0.45 |
| ▸ | MAPT | P10636 | 1/20 | 0.44 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7517332 | 1.00 | ZDHHC7 (0.63) | ZDHHC7GPR84FFAR1ABCB1CA1 | |
| SCHEMBL5812547 | 1.00 | ZDHHC7 (0.63) | ZDHHC7GPR84FFAR1ABCB1CA1 | |
| SCHEMBL19385432 | 1.00 | ZDHHC7 (0.63) | ZDHHC7GPR84FFAR1ABCB1CA1 | |
| SCHEMBL3241254 | 1.00 | ZDHHC7 (0.63) | ZDHHC7GPR84FFAR1ABCB1CA1 | |
| SCHEMBL1683844 | 1.00 | ZDHHC7 (0.63) | ZDHHC7GPR84FFAR1ABCB1CA1 | |
| SCHEMBL5811648 | 1.00 | ZDHHC7 (0.63) | ZDHHC7GPR84FFAR1ABCB1CA1 | |
| SCHEMBL8856372 | 1.00 | ZDHHC7 (0.63) | ZDHHC7GPR84FFAR1ABCB1CA1 | |
| SCHEMBL9097995 | 1.00 | ZDHHC7 (0.63) | ZDHHC7GPR84FFAR1ABCB1CA1 | |
| SCHEMBL2499651 | 1.00 | ZDHHC7 (0.63) | ZDHHC7GPR84FFAR1ABCB1CA1 | |
| SCHEMBL8230931 | 1.00 | ZDHHC7 (0.63) | ZDHHC7GPR84FFAR1ABCB1CA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4482820-A1 | SPHINGOLIPID PRODUCTION | Cataya Bio (Shanghai) Co., Ltd. (CN) | 2025-01-01 | — | — | EP | claimed |
| WO-2024189590-A1 | PRODUCTION OF CERAMIDES | CATAYA BIO (SHANGHAI) CO. (CN) | 2024-09-19 | — | — | WO | claimed |
| WO-2023156605-A1 | SPHINGOLIPID PRODUCTION | CARBOCODE S.A. (PT) | 2023-08-24 | — | — | WO | claimed |
| EP-4368686-B1 | LUBRICITY IMPROVER COMPOSITION FOR FUEL OIL AND USE THEREOF | CHINA PETROLEUM & CHEM CORP (CN) | 2026-05-27 | — | — | EP | disclosed |
| US-12365847-B2 | Lubricity improver composition for fuel oil and use thereof | CHINA PETROLEUM & CHEMICAL CORPORATION (CN) | 2025-07-22 | — | — | US | disclosed |
| EP-4482820-A1 | SPHINGOLIPID PRODUCTION | Cataya Bio (Shanghai) Co., Ltd. (CN) | 2025-01-01 | — | — | EP | disclosed |
| CN-119013246-A | Sphingolipid production | 柯泰亚生物科技(上海)有限公司 | 2024-11-22 | — | — | CN | disclosed |
| US-20240368490-A1 | LUBRICITY IMPROVER COMPOSITION FOR FUEL OIL AND USE THEREOF | Sinopec Research Institute of Petroleum Processing Co., Ltd. (CN) | 2024-11-07 | — | — | US | disclosed |
| WO-2024201287-A1 | PRODUCTION OF SALTS OF SPHINGOID BASES | CATAYA BIO (SHANGHAI) CO. (CN) | 2024-10-03 | — | — | WO | disclosed |
| WO-2024189590-A1 | PRODUCTION OF CERAMIDES | CATAYA BIO (SHANGHAI) CO. (CN) | 2024-09-19 | — | — | WO | disclosed |
| EP-4368686-A1 | LUBRICITY IMPROVER COMPOSITION FOR FUEL OIL AND USE THEREOF | China Petroleum & Chemical Corporation (CN) | 2024-05-15 | — | — | EP | disclosed |
| WO-2023156605-A1 | SPHINGOLIPID PRODUCTION | CARBOCODE S.A. (PT) | 2023-08-24 | — | — | WO | disclosed |
| WO-2017164750-A1 | THERAPEUTIC COMPOSITIONS AND USES THEREOF | MANUKA HEALTH NEW ZEALAND LIMITED (NZ) | 2017-09-28 | — | — | WO | disclosed |
| US-8207370-B2 | Process for producing optically active beta-hydroxy-alpha-aminocarboxylic acid ester | KANEKA CORPORATION (JP) | 2012-06-26 | — | — | US | disclosed |
| US-20100022795-A1 | Process for producing optically active beta-hydroxy-alpha-aminocarboxylic acid ester | KANEKA CORPORATION (JP) | 2010-01-28 | — | — | US | disclosed |
| EP-2067769-A1 | PROCESS FOR PRODUCING OPTICALLY ACTIVE BETA-HYDROXY-ALPHA-AMINOCARBOXYLIC ACID ESTER | Kaneka Corporation (JP) | 2009-06-10 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100022795-A1 | Process for producing optically active beta-hydroxy-alpha-aminocarboxylic acid ester | AADAT, ALAD, ALDH7A1 | ZDHHC7 1337/4885GPR84 442/4885FFAR1 712/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.